A Win For BioLineRx Ltd.
Mon, Dec 14, 2020 at 05:33 PM
BioLineRx Ltd. (BLRX:NASDAQ) jumped higher at $3.39, a gain of 27%. On Fri 11 Dec 20, BLRX:NASDAQ touched a New 2-Week High of $2.67. The stock appeared on our News Catalysts scanner on Fri 11 Dec 20 at 09:03 PM in the 'BIOTECH' category. From Fri 27 Nov 20, the stock recorded 50.00% Up Days and 63.64% Green Days
The stock spiked on Tue 03 Nov 20 at $3.3 with a volume of 50M+, and its share price has been moving sideways in recent weeks.
About BioLineRx Ltd. (BLRX:NASDAQ)
BioLine Rx Ltd is a clinical stage biopharmaceutical development company engaged in identifying, in-licensing & developing therapeutic compounds.
Top 10 Gainers:
- Arvinas, Inc. (ARVN:NASDAQ), 95.06%
- Veru Inc. (VERU:NASDAQ), 52.56%
- Rubius Therapeutics, Inc. (RUBY:NASDAQ), 36.62%
- AnPac Bio-Medical Science Co., Ltd. (ANPC:NASDAQ), 35.07%
- GasLog Partners LP (GLOP:NYSE), 31.18%
- Big Rock Partners Acquisition Corp. (BRPA:NASDAQ), 29.36%
- Alexion Pharmaceuticals, Inc. (ALXN:NASDAQ), 29.2%
- CooTek (Cayman) Inc. (CTK:NYSE), 28.4%
- Teligent, Inc. (TLGT:NASDAQ), 28.21%
- BioLineRx Ltd. (BLRX:NASDAQ), 26.97%